TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
KZR

Kezar Life Sciences Inc

Healthcare · Biotechnology

0.175$ +6.1% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Cash Flow

Kezar Life Sciences Inc (KZR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -52 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow KZR
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-9.8 -8.1 -21 -30 -37 -42 -59 -82 -74 -52
0.2 0.2 0.7 1.3 1.5 1.5 1.0 1.1 1.0 -1.1
0.1 0.2 2.0 4.0 4.9 7.6 14 18 13 9.0
0.1 0.2 2.1 4.0 4.9 7.6 14 – – –
-1.1 0.0 0.1 0.9 -2.0 1.2 -4.5 4.7 -1.3 -5.4
0.1 0.4 1.1 0.6 0.2 0.3 1.6 1.8 0.0 0.0
-0.1 -0.4 -84 20 -56 -28 -91 76 80 92
0.0 50 78 0.3 0.5 2.1 1.3 – – –
– – 9.5 9.5 9.5 9.5 0.0 0.0 0.0 -11
0.0 50 78 0.3 100 113 128 0.6 0.1 -11
-10 41 -27 -9.2 6.3 42 -22 -5.0 6.3 30
-9.9 -8.5 -22 -30 -37 -43 -60 -83 -74 -52

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?